Published in Pharma Investments, Ventures and Law Weekly, September 18th, 2005
In addition, as stated in the company's recent 10Q, dated August 9, 2005, the company is in discussions with several institutional investors and investment firms to renegotiate the duration and terms of its short term (convertible debenture) obligations.
The company is also currently negotiating with a number of potential purchasers for the sale of business units that it has determined are not part of its long term strategy. The sales of these units could generate sufficient funds to satisfy debt...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly